![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1584, 2007-01, pp. : 18-18
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Triptan use in migraine curbed by cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Eletriptan: A Review of its Use in the Acute Treatment of Migraine
By McCormack Paul L. Keating Gillian M.
Drugs, Vol. 66, Iss. 8, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Spotlight on Eletriptan in Migraine
By McCormack Paul L. Keating Gillian M.
CNS Drugs, Vol. 20, Iss. 11, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Triptan properties related to migraine recurrence
Inpharma, Vol. 1, Iss. 1389, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Eletriptan reduces lost work time from migraine
Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. :